Literature DB >> 8809231

Epidemiology of inflammatory bowel disease.

B A Lashner1.   

Abstract

The search for the cause of inflammatory bowel disease through epidemiologic investigation is centered on documenting disease variability and determining the reason for such variability. An examination of the person, place, and time variability of inflammatory bowel disease can provide important clues to disease pathogenesis. Although there is a great deal of variability in the epidemiology of inflammatory bowel disease among populations, there is little difference in these populations between Crohn's disease and ulcerative colitis with regard to person, place, or time variability. With notable exceptions, such as cigarette smoking, the epidemiologic variability of ulcerative colitis and Crohn's disease is remarkably similar. Such similarities are unlikely to be coincidences. The possible implications from this observation are that ulcerative colitis and Crohn's disease are actually different expressions of the same disease, expressions determined by such factors as cigarette smoking, or that two separate diseases share a near complete set of risk factors. Whichever theory is correct, environmental risk factors, which are preventable, are certain to be involved in causative mechanisms.

Entities:  

Mesh:

Year:  1995        PMID: 8809231

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  10 in total

1.  Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

Authors:  John V Raelson; Randall D Little; Andreas Ruether; Hélène Fournier; Bruno Paquin; Paul Van Eerdewegh; W E C Bradley; Pascal Croteau; Quynh Nguyen-Huu; Jonathan Segal; Sophie Debrus; René Allard; Philip Rosenstiel; Andre Franke; Gunnar Jacobs; Susanna Nikolaus; Jean-Michel Vidal; Peter Szego; Nathalie Laplante; Hilary F Clark; René J Paulussen; John W Hooper; Tim P Keith; Abdelmajid Belouchi; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

2.  Colonoscopy in Hong Kong Chinese children.

Authors:  Yuk Him Tam; Kim Hung Lee; Kin Wai Chan; Jennifer Dart Yin Sihoe; Sing Tak Cheung; Jennifer Wai Cheung Mou
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

3.  Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Daniel Araki Ribeiro; Roseane Mendes Silva; Patrícia Marchi; Celina Tizuko Fujiyama Oshima; Ricardo Artigiani Neto; Sender Jankiel Miszputen; Marcello Franco
Journal:  J Mol Histol       Date:  2012-03-20       Impact factor: 2.611

Review 4.  Diet and the intestinal microbiome: associations, functions, and implications for health and disease.

Authors:  Lindsey G Albenberg; Gary D Wu
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

5.  Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression.

Authors:  Ana Paula Ribeiro Paiotti; Sender Jankiel Miszputen; Celina Tizuko Fujiyama Oshima; Ricardo Artigiani Neto; Daniel Araki Ribeiro; Marcello Franco
Journal:  J Mol Histol       Date:  2011-08-24       Impact factor: 2.611

Review 6.  Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children.

Authors:  Theresa A Mikhailov; Sylvia E Furner
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Sender Jankiel Miszputen; Celina Tizuko Fujiyama Oshima; Henrique de Oliveira Costa; Daniel Araki Ribeiro; Marcello Franco
Journal:  J Mol Histol       Date:  2009-11-22       Impact factor: 2.611

Review 8.  Food and the gut microbiota in inflammatory bowel diseases: a critical connection.

Authors:  Lindsey G Albenberg; James D Lewis; Gary D Wu
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

9.  Characteristic phenotypes in Korean Crohn's disease patients who underwent intestinal surgery for the treatment.

Authors:  Seung Hyuk Baik; Kyu Joo Park; Kang Young Lee; Yong Beom Cho; Gyu-Seog Choi; Kil Yeon Lee; Sang Nam Yoon; Chang Sik Yu
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

10.  Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.

Authors:  Mohammad A Al-Mofarreh; Ibrahim A Al-Mofleh
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.